Document is current
Any future updates will be listed below
-
Authors
Kady, Mohamed R. https://orcid.org/0000-0003-1568-6394
Elston, R. Nicholas https://orcid.org/0009-0003-6855-9476
Snyder, Lauren J. https://orcid.org/0009-0005-8173-0367
Fleischman, Jorie D. https://orcid.org/0009-0005-7243-3950
Brandt, Madilyn J. https://orcid.org/0009-0007-0475-0748
Zhu, Duolong https://orcid.org/0000-0002-8048-2171
Britton, Robert A. https://orcid.org/0000-0001-8983-9539
Beeton, Christine https://orcid.org/0000-0002-2500-5874
-
Funding
Funding for this research was provided by:
National Institute of Allergy and Infectious Diseases (F30 AI181286)
National Institute of Allergy and Infectious Diseases (R01 AI173318)
National Heart, Lung, and Blood Institute (T32 HL170967)
U.S. Department of Defense (W81XWH-22-1-0036)
- License Information
-
More Information
Article History
Received: 28 March 2025
Accepted: 17 July 2025
First Online: 2 August 2025
Declarations
:
: All animal experiment protocols were approved by the Institutional Animal Care and Use Committee at Baylor College of Medicine.
: Not applicable.
: CB is an inventor on the patent protecting ShK-186, currently in clinical trials for the treatment of autoimmune diseases. CB and RAB are inventors on a patent disclosure protecting LrS235. RAB is a cofounder of Mikrovia and PanaBio.
